Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Forte Biosciences, Inc. in our court records and SEC 8-K records (as of 2026-10-18).
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Orbimed Advisors LLC (filed 2026-08-14).
Who is behind it
Forte Biosciences, Inc.: incorporated in Delaware; business address in Dallas, Texas; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-09-08).
Officers and directors, each with the role and the filing that names them:
- Paul Wagner: Executive Officer, Director (Form D, 2023-08-09)
- Hubert Chen: Executive Officer (Form D, 2023-08-09)
- Antony Riley: Executive Officer (Form D, 2023-08-09)
- Lawrence Eichenfield: Director (Form D, 2023-08-09)
- David Gryska: Director (Form D, 2023-08-09)
- Scott Brun: Director (Form D, 2023-08-09)
- Steven Kornfeld: Director (Form D, 2023-08-09)
- Stephen Doberstein: Director (Form D, 2023-08-09)
- Donald Williams: Director (Form D, 2023-08-09)
- Barbara Fink: Director (Form D, 2023-08-09)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-09-08 | Federated Hermes, Inc. | 0% |
| Schedule 13G/A, 2026-08-14 | Orbimed Advisors LLC | 6.2% |
| Schedule 13G/A, 2026-08-13 | Janus Henderson Group LTD. | 9.3% |
| Schedule 13G/A, 2026-08-13 | Affinity Asset Advisors, LLC | 5.6% |
| Schedule 13G/A, 2026-08-12 | Adage Capital Management, L.P. | 3.42% |
| Schedule 13G, 2026-08-11 | Glazer Capital, LLC | 1.46% |
| Schedule 13G/A, 2026-08-07 | Alger Associates, Inc. | 4.6% |
| Schedule 13G/A, 2026-08-07 | Janus Henderson Group LTD. | 2.5% |
Money raised
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2023-08-09 | $25.01M | $25.01M |
Acquisitions reported on Form 8-K, Item 2.01: completed an acquisition (2026-08-27).
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
Permanent URL:
https://mentionfox.com/who-owns/forte-biosciencesLast updated 2026-10-18
Primary record: Schedule 13G/A, 2026-08-14 · Form D, 2023-08-09
Who owns Forte Biosciences, Inc.? Owners, funding and legal record. MentionFox, 2026-10-18. https://mentionfox.com/who-owns/forte-biosciences
